Redefining Early Stage Investments (RESI)
Conference Series

Connecting Early Stage Products With Capital & Channel Partners

Upcoming RESIs:

RESI Conference Series

Helping fund life science companies from Grants to Series B

The Redefining Early Stage Investments (RESI) conference series was created by Life Science Nation (LSN) to bring together startups with early-stage investors and strategic channel partners. The goal was to maximize the capability of these companies, from seed to series B, to find partners who are a fit for their technology and stage of development. What‘s unique about RESI is that the event is cross border and cross domain, connecting startups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health, the “4 Ds”. RESI caters to both the earliest stage startups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding.

  • 1:1 Ratio of Entrepreneurs to Investors
  • Cutting-edge Technologies across Drugs, Devices, Diagnostics, & Digital Health
  • 10 Type of Early-Stage Investors from North America, Europe, Asia…
  • A Full Day of One-to-One Partnering Meetings and Networking
  • Insightful Investor Panels and Entrepreneur Workshops
  • Global Gathering of Tech Hubs & Their Constituents

LSN invites tech hubs, entrepreneurs, investors, strategic partners, and service providers to the RESI Conference.

Digital RESI Overview

Customer Testimonials

“We have been a long time RESI attendees as we have recognized the value that it brings in connecting entrepreneurs with early stage investors like us. The Digital RESI will allow us to continue, and expand, the opportunity to interact while we circumvent travel and meeting restrictions.”

Christopher de Souza
Director, Broadview Ventures

“As Title Sponsor we are pleased to see responsible choices being made about taking RESI Europe digital, and we’re excited to see partnering expand from a one day physical event to a three day virtual event… Our workshop on “Negotiating Term Sheets” will provide a great learning opportunity to all of the investors and fundraising CEOs who need this critical information.”

Angus McQuilken
Industry Relationship Executive – Life Sciences, McDermott Will & Emery

Incubators, tech transfer offices, universities, hospitals, research labs and their constituents to get on the radar of investors and channel partners. Biotech, Medtech, Diagnostics and Digital Health to source global investors and strategic partners, create relationships, and potentially, secure funding
Tech Hubs & Their Constituents Early Stage Fundraising Companies
Seeking $15K – $2M Seeking $2M – $10M+
Grants – Seed – Angel Series A – Series B